(Q53312438)

13 May 2018

title

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. (English)

1 reference

13 May 2018

author

Valentina Ambrosini

1

1 reference

13 May 2018

Davide Campana

4

1 reference

13 May 2018

author name string

Cristina Nanni

2

1 reference

13 May 2018

Maurizio Zompatori

3

1 reference

13 May 2018

Paola Tomassetti

5

1 reference

13 May 2018

Paolo Castellucci

6

1 reference

13 May 2018

Vincenzo Allegri

7

1 reference

13 May 2018

Domenico Rubello

8

1 reference

13 May 2018

Giancarlo Montini

9

1 reference

13 May 2018

Roberto Franchi

10

1 reference

13 May 2018

Stefano Fanti

11

1 reference

13 May 2018

publication date

27 January 2010

1 reference

13 May 2018

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

13 May 2018

volume

37

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

722-727

1 reference

13 May 2018

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

cites work

1 reference

12 December 2020

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

1 reference

12 December 2020

Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?

1 reference

12 December 2020

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

1 reference

12 December 2020

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation.

1 reference

12 December 2020

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

1 reference

12 December 2020

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

1 reference

12 December 2020

Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

1 reference

12 December 2020

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

1 reference

12 December 2020

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

1 reference

12 December 2020

The Measurement of Observer Agreement for Categorical Data

1 reference

12 December 2020

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

1 reference

12 December 2020

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

1 reference

12 December 2020

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

1 reference

12 December 2020

Nuclear imaging of neuroendocrine tumours

1 reference

12 December 2020

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

12 December 2020

Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.

1 reference

12 December 2020

10.1007/S00259-009-1349-9

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018